Editorial: Reading the cholate-A new gateway to portal hypertension and oesophageal varices: Authors' reply
Aliment Pharmacol Ther
.
2024 Aug;60(3):405-406.
doi: 10.1111/apt.18128.
Epub 2024 Jun 25.
Authors
Tarek Hassanein
1
,
Andrew P Keaveny
2
,
Parvez Mantry
3
,
Alastair D Smith
4
,
Michael P McRae
5
,
John Kittelson
6
,
Steve Helmke
7
,
Gregory T Everson
7
;
SHUNT‐V Investigators
Affiliations
1
Southern California Research Center, Coronado, California, USA.
2
Mayo Clinic, Jacksonville, Florida, USA.
3
The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas, USA.
4
Syneos Health, Morrisville, North Carolina, USA.
5
Custom DX Solutions LLC, Houston, Texas, USA.
6
Consultant to HepQuant, LLC, Denver, Colorado, USA.
7
HepQuant, LLC, Denver, Colorado, USA.
PMID:
38924551
DOI:
10.1111/apt.18128
No abstract available
Publication types
Editorial
Comment
MeSH terms
Esophageal and Gastric Varices* / etiology
Humans
Hypertension, Portal* / complications
Hypertension, Portal* / physiopathology
Grants and funding
M01RR-00051/DK/NIDDK NIH HHS/United States
M01RR-00065/DK/NIDDK NIH HHS/United States
M01RR-00827/DK/NIDDK NIH HHS/United States
M01RR-00051/DK/NIDDK NIH HHS/United States
M01RR-00065/DK/NIDDK NIH HHS/United States
M01RR-00827/DK/NIDDK NIH HHS/United States